Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
6.47
0.00 (0.00%)
May 12, 2025, 11:15 AM - Market open
Valneva SE Employees
Valneva SE had 713 employees as of December 31, 2024. The number of employees increased by 37 or 5.47% compared to the previous year.
Employees
713
Change (1Y)
37
Growth (1Y)
5.47%
Revenue / Employee
$282,047
Profits / Employee
-$121,861
Market Cap
532.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VALN News
- 10 hours ago - Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States - GlobeNewsWire
- 3 days ago - Valneva SE (VALN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance - Seeking Alpha
- 4 days ago - Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly - GlobeNewsWire
- 5 days ago - Europe reviews Valneva's chikungunya vaccine after reports of serious side-effects in older people - Reuters
- 5 days ago - Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 15 days ago - Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities - GlobeNewsWire
- 24 days ago - Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers - GlobeNewsWire